Learn More
Description
The BerH8 monoclonal antibody specifically binds to CD30. CD30 is a 120 kDa type I transmembrane glycoprotein that is expressed on stimulated T and B cells. CD30 is an activation marker which that initially identified to be expressed on Reed-Sternberg cells. It is also expressed on a few extrafollicular T and B cells located at the rim of germinal centers. CD30 serves as a cytokine receptor. It belongs to the nerve growth factor receptor/tumor necrosis factor receptor (NGFR/TNFR) superfamily and is also known as TNFRSF8. CD30 interaction with CD30 ligand (CD30L/CD153/TNFSF8) can mediate signals for proliferation, apoptosis and cytotoxicity of lymphoid cells.
Specifications
Specifications
| Antigen | CD30 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | BERH8 |
| Concentration | 0.5mg/mL |
| Conjugate | Unconjugated |
| Description | TNFRSF8; TNR8; CD30L/CD153 receptor; Ki-1; D1S166E |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Mouse |
| Purification Method | Affinity Purified |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.